Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Monthly Archives: February 2023

MissionIRNewsBreaks – Cepton Inc. (NASDAQ: CPTN) Launches Epitome of Everything That Matters in Lidar Manufacturing

Posted on February 13, 2023 by MissionIR

Cepton (NASDAQ: CPTN) recently announced the launch of its latest innovative product: a new game-changing lidar called Vista(R)-X120 Plus. “Building on Cepton’s existing Vista-X90 lidar – an already established, groundbreaking automotive-grade lidar expected to be deployed in the company’s flagship … Continue reading →

Posted in Cepton Inc. CPTN | Leave a comment

MissionIRNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Files Patent for Treatment of Alzheimer’s

Posted on February 13, 2023 by MissionIR

Silo Pharma (NASDAQ: SILO), a developmental stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic research, today announced that it has filed a provisional patent application for the use of its central nervous system (“CNS”) homing peptides to treat … Continue reading →

Posted in Silo Pharma Inc. SILO | Leave a comment

MissionIRNewsBreaks – Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR) Completes Acquisition of the Bahia Project

Posted on February 13, 2023 by MissionIR

Energy Fuels (NYSE American: UUUU) (TSX: EFR) today announced completion of its acquisition of 17 mineral concessions between the towns of Prado and Caravelas in the state of Bahia, Brazil, totaling 15,089.71 hectares (approximately 37,300 acres or 58.3 square miles). … Continue reading →

Posted in Energy Fuels Inc. UUUU | Leave a comment

BiondVax Pharmaceuticals Ltd.’s (NASDAQ: BVXV) COVID-19 NanoAb Takes Centerstage at the 2023 BIO CEO & Investor Conference

Posted on February 13, 2023 by MissionIR

BiondVax Pharmaceuticals (NASDAQ: BVXV), a biotechnology company focused on developing, manufacturing, and commercializing innovative immunotherapeutic products mainly for treating infectious and autoimmune diseases, took part in the 2023 BIO CEO & Investor Conference held at the Marriott Marquis, New York. … Continue reading →

Posted in BiondVax Pharmaceuticals Ltd. BVXV | Leave a comment

MissionIRNewsBreaks – Eloro Resources Ltd. (TSX.V: ELO) (OTCQX: ELRRF) (FSE: P2QM) CEO Discusses Promising Drill Results in New Interview

Posted on February 10, 2023 by MissionIR

Eloro Resources (TSX.V: ELO) (OTCQX: ELRRF) (FSE: P2QM) is an exploration and mine development company with a portfolio of gold and base-metal properties in Bolivia, Peru and Quebec. The company was featured in a new video interview where its CEO … Continue reading →

Posted in Eloro Resources Ltd. ELRRF | Leave a comment

MissionIRNewsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) DehydraTECH-CBD Demonstrates Higher Absorption at Lower Dose Levels

Posted on February 10, 2023 by MissionIR

Lexaria Bioscience Corp. (NASDAQ: LEXX) recently announced it had demonstrated superior CBD blood absorption levels from its patented DehydraTECH(TM)-processed CBD compared to those of published comparators. “In their analysis, Lexaria’s researchers compared the average blood plasma levels of DehydraTECH-CBD at … Continue reading →

Posted in Lexaria Bioscience Corp. LEXX | Leave a comment

MissionIRNewsBreaks – Correlate Infrastructure Partners Inc. (CIPI) Poised amid Wider Adoption of Clean Energy Solutions

Posted on February 10, 2023 by MissionIR

Correlate Infrastructure Partners (OTCQB: CIPI), a tech-enabled development, finance and fulfillment platform for distributed energy solutions across North America, understands the weight of the current climate situation. “Correlate is optimistic that its affordable energy solutions will not only initiate but … Continue reading →

Posted in Correlate Infrastructure Partners Inc. CIPI | Leave a comment

MissionIRNewsBreaks – Data443 Risk Mitigation Inc. (ATDS) Implementing Measures to Fuel Growth

Posted on February 10, 2023 by MissionIR

Data443 Risk Mitigation (OTC: ATDS), a data security and privacy software company, is committed to identifying and protecting all sensitive data regardless of location, platform or format. “Boasting over 10,000 customers in over 100 countries, Data443 has recently highlighted a … Continue reading →

Posted in Data443 Risk Mitigation Inc. ATDS | Leave a comment

Lexaria Bioscience Corp. (NASDAQ: LEXX) Expecting Additional Growth in 2023, Including IND Filing and IND Clinical Study

Posted on February 10, 2023 by MissionIR

Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, has released its new corporate presentation (https://ir.lexariabioscience.com/presentations). The presentation augments the positive outlook for the coming year put forth in an earlier released shareholder update letter from the company’s … Continue reading →

Posted in Lexaria Bioscience Corp. LEXX | Leave a comment

MissionIRNewsBreaks – McEwen Mining Inc. (NYSE: MUX) (TSX: MUX) Well Positioned as Gold and Copper Forecasts Point to Higher Prices

Posted on February 9, 2023 by MissionIR

McEwen Mining (NYSE: MUX) (TSX: MUX) is an asset-rich diversified gold and silver producer with large exposure to copper through its subsidiary, McEwen Copper. “[MUX] is led by a management team with extensive knowledge and experience in the mining space … Continue reading →

Posted in McEwen Mining Inc. MUX | Leave a comment